phase III clinical study
AstraZeneca Taking Enhertu, Perjeta Breast Cancer Data to Regulators
Interim results from a Phase III trial showed the combo benefited HER2-positive metastatic breast cancer patients in the first-line setting.
Gilead Sharing Keytruda, Trodelvy Triple-Negative Breast Cancer Data With Regulators
In a Phase III trial, the Keytruda-Trodelvy combo improved progression-free survival in patients with PD-L1-positive tumors compared to Keytruda-chemo.
Emory U Enrolling Heart Failure Patients into BioCardia's Follow-up CardiAMP Cell Therapy Trial
After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.
BrainStorm Submits IND Amendment Hoping to Move Ahead With Phase IIIb NurOwn ALS Trial
BrainStorm has attempted to gain market approval for NurOwn without success but remains committed to developing the cell therapy.
On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 gene therapy.
Apr 1, 2025
Jan 30, 2025